SCHEMBL4493801

SCHEMBL4493801

Cc1cccc(C)c1-c1ccc2c(NC(=O)C(c3ccccc3)c3ccccc3)n[nH]c2c1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 8/20 0.51
HDAC6 Q9UBN7 2/20 0.49
GSK3A P49840 2/20 0.49
FGFR1 P11362 2/20 0.48
FGFR2 P21802 2/20 0.48
FGFR3 P22607 2/20 0.48
AAK1 Q2M2I8 5/20 0.46
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
MAPK1 P28482 1/20 0.44
DYRK1A Q13627 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4497956 0.89 GSK3B (0.52) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4504699 0.87 GSK3B (0.56) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4480572 0.87 FGFR1 (0.47) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4498346 0.87 GSK3B (0.62) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4493797 0.86 AAK1 (0.58) GSK3BHDAC6GSK3AAAK1MAPK1
SCHEMBL4502518 0.86 GSK3B (0.65) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4494390 0.84 GSK3B (0.49) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4493014 0.83 MAPK1 (0.53) GSK3BHDAC6GSK3AFGFR1FGFR2
SCHEMBL4480768 0.83 FGFR1 (0.69) GSK3BHDAC6FGFR1FGFR2FGFR3
SCHEMBL4482990 0.83 GSK3B (0.65) GSK3BHDAC6GSK3AFGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed